Abstract. The aim of the present study was to investigate the effects of Beclin 1 knockdown on spontaneous and vitamin K 3 (VK 3 )-regulated autophagy, survival and apoptosis in human hepatocarcinoma SMMc-7721 cells, and to explore the potential mechanisms underlying the action of Beclin 1 knockdown in the processes of autophagy and apoptosis. a recombinant plasmid-expressing small interfering rna (sirna) targeting Beclin 1 mrna was constructed and introduced into SMMc-7721 cells. The expression of Beclin 1 was determined by reverse transcription-polymerase chain reaction and Western blotting. Subsequently, the impact of Beclin 1 knockdown on spontaneous and VK 3 -induced autophagy, survival and apoptosis was determined. The expression of cyclin d1, cyclindependent kinase 4 (cdK4), Bcl-2, Bcl-xl and the activation of caspase-3 were examined by Western blotting. Transfection with the plasmid for Beclin 1 sirna expression dramatically down-regulated Beclin 1 expression in SMMc-7721 cells. The knockdown of Beclin 1 expression significantly inhibited spontaneous and VK 3 -induced autophagy, but did not affect spontaneous proliferation and apoptosis in SMMc-7721 cells in vitro. By contrast, the silencing of Beclin 1 expression significantly enhanced the inhibition of survival and proliferation by VK 3 , and promoted VK 3 -induced apoptosis by significantly down-regulating cyclin D1, CDK4, Bcl-2 and Bcl-xl expression and enhancing caspase-3 activation in SMMc-7721 cells in vitro. our data indicate that Beclin 1 is a positive regulator of autophagy, but a negative regulator of VK 3 -induced apoptosis in human hepatoma cells.